Results for “”

Entry Author Date Location
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials 05/09/19 National
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea 05/06/19 New York
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments 05/03/19 National
Beyond Meat’s IPO Bags $241M to Make Plant-Based Burgers Mainstream 05/02/19 National
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease? 05/02/19 National
Retailers, Startups Work to Offer Efficient E-Commerce Delivery 05/01/19 National
Publishers Cengage, McGraw-Hill Merge to Better Target Edtech Market 05/01/19 Boston
Another $568M, and a $7B Valuation, for Automation Firm UiPath 04/30/19 San Francisco
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Dave, More Chips on Aisle 3: Walmart Opens AI-Enabled Store in NY 04/25/19 New York
Teva’s Approved Migraine Drug Fails Again to Blunt Rarer Headache 04/23/19 New York
SPECIAL REPORT: 2019 Blockchain Outlook — Reality Check 04/23/19 National
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson 04/23/19 Boston
Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer 04/22/19 New York
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants 04/18/19 Boston
Alzheimer’s, Gene Therapy & More: Agenda For “What’s Hot” on May 21 04/16/19 Boston
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon 04/15/19 New York
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
Alnylam Makes Case For 2nd RNAi Drug at Big Liver Disease Meeting 04/12/19 Boston
Lyft, Uber, and the Changing Disclosure Rules For Unicorn IPOs 04/12/19 San Francisco
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout 04/12/19 New York
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More 04/12/19 National
Intercept Touts a Smaller Piece of Its NASH Trial at Liver Conference 04/11/19 New York
Senators Grill Pharmacy Benefit Execs About Skyrocketing Drug Prices 04/09/19 National
VC Trends in 2019: More Money, Fewer Deals But Women Still Get Less 04/09/19 National
CD&R Buys Majority Stake in San Antonio’s Sirius Computer Solutions 04/08/19 Texas
Trevi Therapeutics Files for IPO to Fund Anti-Itching Drug R&D 04/08/19 New York
Page 2 of 83 « previous page · next page »